Senti Biosciences (SNTI) Assets Average (2021 - 2025)

Senti Biosciences has reported Assets Average for 5 years, with the latest figure at $52.0 million in Q4 2025.

• For the quarter ending Q4 2025, Assets Average fell 33.2% year-over-year to $52.0 million; the trailing twelve-month figure through Dec 2025 stood at $52.0 million (down 33.2% YoY), and the FY2025 full-year result was $74.5 million, down 31.41% from the prior year.
• Assets Average for Q4 2025 stood at $52.0 million, down from $60.6 million in the prior quarter.
• The five-year high for Assets Average was $231.8 million in Q3 2021, with the low at $52.0 million in Q4 2025.
• Average Assets Average over 5 years is $131.3 million, with a median of $125.6 million recorded in 2023.
• Year-over-year, Assets Average soared 86.55% in 2022 and sank 47.48% in 2024.
• Tracing SNTI's Assets Average over 5 years: stood at $164.2 million in 2021, then rose by 12.75% to $185.1 million in 2022, then plunged by 32.14% to $125.6 million in 2023, then plunged by 38.08% to $77.8 million in 2024, then plunged by 33.2% to $52.0 million in 2025.
• The last three Assets Average figures came in at $52.0 million (Q4 2025), $60.6 million (Q3 2025), and $75.7 million (Q2 2025), per Business Quant data.

Peer Comparison